The resulting recommendations are based on an extensive review of the medical literature and reflect consensus among this panel of HCV experts.Each recommendation is rated for strength and for quality of the evidence (see Recommendation Rating Scheme, below).Recommendation Rating Scheme: Hepatitis C Virus Infection Guideline Committee, July 2017 More than 50% of people with chronic hepatitis C virus (HCV) infection may not be aware of their infection .Because approximately 75% of cases are among persons born between 19 [1-3], age-cohort screening of asymptomatic adults with no recognized risk factors is thought to increase identification and treatment for these patients.
In New York State (including New York City), the mortality rate associated with HCV increased from 4.0 per 100,000 population in 2001 to 5.5 per 100,000 population in 2015 .
The Centers for Disease Control and Prevention (CDC) reported 162,863 cases of chronic HCV infection (past or present) nationwide in 2015 .
The number of reported cases in New York State (excluding New York City) and New York City for 2015 are provided in Box 1.
The availability of safe and effective regimens of oral DAAs has revolutionized HCV care.
New DAA agents and new combinations of agents continue to be tested and approved, and these efficacious combinations have replaced earlier treatments as the standard of care for curing chronic HCV infection.